Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Cellect Biotechnology Ltd (APOP) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7890
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:39
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Cellect Biotechnology Ltd (Cellect Biotechnology) formerly Cellect Biomed Ltd is a clinical stage biotechnology company which develops stem cell selection technologies for the production of stem cells based products in the field of regenerative medicine. The company’s technology platform is developing ApoGraft solutions which provides functional selection of stem and progenitor cells through an apoptotic process with focus on hematopoietic cells field. It is developing ApoTainer selection kit, a off-the-shelf medical device product for use in bone marrow transplantation, immune disorders and organ transplantations. The company offers licensing opportunities to pharmaceutical companies, medical research centers, academies and hospitals with the tools to rapidly isolate stem cells and allow stem cell related treatments and procedures. Cellect Biotechnology is headquartered in Kfar Saba, Israel.

Cellect Biotechnology Ltd (APOP) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cellect Biotechnology Ltd, Medical Equipment, Deal Details 11
Partnerships 11
Cellect Biomed Enters into Co-Development Agreement with Entegris 11
Equity Offering 12
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 12
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 13
Cellect Biomed Raises USD2 Million in Private Placement of Shares 15
Cellect Biotechnology Ltd – Key Competitors 16
Cellect Biotechnology Ltd – Key Employees 17
Cellect Biotechnology Ltd – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Financial Announcements 19
May 17, 2018: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2018 Financial Results 19
Mar 19, 2018: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results 20
Nov 22, 2017: Cellect Biotechnology Provides Corporate Update and Reports Third Quarter 2017 Financial Results 22
Aug 21, 2017: Cellect Biotechnology Provides Corporate Update and Reports Second Quarter 2017 Financial Results 23
May 29, 2017: Cellect Biotechnology Provides Corporate Update and Reports First Quarter 2017 Financial Results 24
Mar 23, 2017: Cellect Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2016 Financial Results 25
Corporate Communications 27
May 10, 2018: Former GE Healthcare Executive to Join Cellect as Chief Business Officer 27
May 23, 2017: David Braun, Head of Merck Device Business, Joins Cellect’s Advisory Board 28
Mar 02, 2017: Michael Berelowitz MD., Former Head, Clinical Development and Medical Affairs, Pfizer Specialty Care Business Unit Joins Cellect’s Board of Directors 29
Feb 23, 2017: World-Renowned Stem Cell Transplantation Expert joins Cellect’s Advisory Board 30
Jan 30, 2017: Dr. Yaron Pereg Appointed as New Chief Development Officer 31
Jan 03, 2017: Cellect Announces Appointment of Eyal Leibovitz, Experienced Life Sciences Industry and Financial Executive, as Chief Financial Officer 32
Legal and Regulatory 33
Jun 09, 2017: Cellect is Moving to Trade Exclusively on the NASDAQ 33
Feb 14, 2017: Dual-Listed Cellect to Voluntarily File for Delisting from Tel Aviv Stock Exchange 34
Product News 35
Jun 12, 2017: Cellect Receives Notice of Allowance from the US Patent & Trademark Office 35
Apr 03, 2017: Cellect Receives Notice of Intention to Grant from European Patent Office for Patent Protecting Company’s Technology in Multiple Indications 36
Jan 12, 2017: Cellect Receives Patent Notice of Allowance from US Patent & Trademark Office Protecting Company’s Technology in Multiple Key Indications 37
Other Significant Developments 38
Apr 09, 2018: Cellect Announces a Major Milestone for Enabling Stem Cells Production 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List of Tables
Cellect Biotechnology Ltd, Medical Equipment, Key Facts, 2016 2
Cellect Biotechnology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Deals By Market, 2012 to YTD 2018 9
Cellect Biotechnology Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
Cellect Biomed Enters into Co-Development Agreement with Entegris 11
Cellect Biotechnology to Raise USD4 Million in Private Placement of American Depositary Shares 12
Cellect Biotechnology Raises USD8.4 Million in IPO of ADS 13
Cellect Biomed Raises USD2 Million in Private Placement of Shares 15
Cellect Biotechnology Ltd, Key Competitors 16
Cellect Biotechnology Ltd, Key Employees 17

List of Figures
Cellect Biotechnology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Cellect Biotechnology Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
Cellect Biotechnology Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
Cellect Biotechnology Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
Cellect Biotechnology Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[Cellect Biotechnology Ltd (APOP):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Dome Investments Public Company Limited:企業の戦略・SWOT・財務情報
    Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary Dome Investments Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Swift Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Swift Biosciences Inc (Swift Biosciences) is a biotechnology company that develops novel research reagents, protocols, and molecular diagnostic tools. The company’s products include 2S hyb DNA library kit, 2S plus DNA library kit, 2S PCR-free DNA library kit, methyl-seq DNA library kit, DNA …
  • Aminex PLC (AEX):石油・ガス:M&Aディール及び事業提携情報
    Summary Aminex PLC (Aminex) is an oil and gas company that explores, develops and produces oil and gas reserves in Africa. The company provides assets such as Valeni field and Viktorovka field in Moldova; West Esh el Mellaha-2 in Egypt; and Kiliwani North development, Nyuni exploration, and Ruvuma e …
  • Cereno Scientific AB (CRNO TO):製薬・医療:M&Aディール及び事業提携情報
    Summary Cereno Scientific AB (Cereno Scientific) is a developer of preventive drugs that normalize the body's own defense system against blood clots. The company develops drugs in the therapeutic area of thrombosis-related cardiovascular diseases. Its lead product candidate CS1 is being developed fo …
  • Modern Times Group MTG AB:企業の戦略・SWOT・財務分析
    Modern Times Group MTG AB - Strategy, SWOT and Corporate Finance Report Summary Modern Times Group MTG AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sorgenia SpA:企業の戦略的SWOT分析
    Sorgenia SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Shanxi Zhendong Pharmaceutical Co Ltd (300158):製薬・医療:M&Aディール及び事業提携情報
    Summary Shanxi Zhendong Pharmaceutical Co Ltd (Zhendong Group) is a pharmaceutical company. The company researches, develops, manufactures and markets pharmaceutical products and Chinese medicines in China. It offers products such as cancer drugs, cardiovascular drugs, infectious disease drugs, resp …
  • Duravit AG:企業の戦略・SWOT・財務分析
    Duravit AG - Strategy, SWOT and Corporate Finance Report Summary Duravit AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Flatiron Health Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Flatiron Health Inc (Flatiron Health) a subsidiary of F. Hoffmann-La Roche Ltd, is a healthcare technology company which develops a learning healthcare system in oncology. The company offers a web-based business and clinical intelligence data platform that integrates and structures disparate …
  • Dunelm Group plc (DNLM):企業の財務・戦略的SWOT分析
    Dunelm Group plc (DNLM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • WGL Holdings Inc (WGL):企業の財務・戦略的SWOT分析
    WGL Holdings Inc (WGL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Reliance Infrastructure Ltd (RELINFRA):企業の財務・戦略的SWOT分析
    Reliance Infrastructure Ltd (RELINFRA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Recreational Equipment Inc:企業の戦略・SWOT・財務情報
    Recreational Equipment Inc - Strategy, SWOT and Corporate Finance Report Summary Recreational Equipment Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Thermo Fisher Scientific Inc.:企業の戦略・SWOT・財務情報
    Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report Summary Thermo Fisher Scientific Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Gritstone Oncology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Gritstone Oncology Inc (Gritstone) is a cancer immunotherapy company which focuses on the development of personalized cancer therapeutics. The company primarily concentrates on identifying and deploying the therapeutic neo-antigens from individual patients’ tumors for the development of nove …
  • Aviva plc:企業のM&A・事業提携・投資動向
    Aviva plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Aviva plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Metropolitan Bank & Trust Company (MBT):企業の財務・戦略的SWOT分析
    Metropolitan Bank & Trust Company (MBT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • BioTime Inc (BTX):企業の財務・戦略的SWOT分析
    BioTime Inc (BTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothera …
  • Price Forbes & Partners Ltd.:企業の戦略・SWOT・財務情報
    Price Forbes & Partners Ltd. - Strategy, SWOT and Corporate Finance Report Summary Price Forbes & Partners Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆